Condition
Thyroid Gland Disease
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07328113Completed
Interleukin-6 and Thyroid Dysfunction in Hemodialysis Patients
NCT07057570Completed
Comparison of Pre Existing Intra Operative Thyroidectomy Difficulty Score With Novel Difficult Thyroidectomy Predictor Score in Prediction of Difficult Thyroidectomies
NCT05396703CompletedPrimary
TOETVA Feasibility and Complications - Single Center First Experience
NCT04249271CompletedPrimary
Antithyroidal Antibodies With or Without Subclinical Hypothyroidism During Pregnancy in Infertile Women
Showing all 4 trials